Effect of thoracoscopic talc poudrage vs talc slurry via chest tube on pleurodesis failure rate among patients with malignant pleural effusions: A randomized clinical trial
JAMA Jan 14, 2020
Bhatnagar R, Piotrowska HEG, Laskawiec-Szkonter M, et al. - Researchers performed an open-label, randomized clinical trial at 17 UK hospitals in order to determine whether the administration of talc poudrage during thoracoscopy with local anesthesia is more effective than talc slurry delivered via chest tube in successfully inducing pleurodesis. They enrolled a sum of 330 individuals from August 2012 to April 2018 and followed up until October 2018. They noted that the pleurodesis failure rate was 36 of 161 patients (22%) in the talc poudrage group and 38 of 159 (24%) in the talc slurry group at 90 days. In comparison with talc slurry delivered via chest tube, no significant difference was found in the rate of pleurodesis failure among patients with malignant pleural effusion, thoracoscopic talc poudrage. Although, the research may have been underpowered to find small but potentially important differences.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries